EW
Edwards Lifesciences Corp
NYSE · Healthcare · Medical - Devices · US
$86.18
−0.62%Price chart
Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9
ValuationView details →
P/E (Fwd)
27.4x
EV/EBITDA
30.0x
Market Cap
$49.67B
MomentumView details →
1D Return
−0.62%
YTD Return
+0.96%
RSI (14)
34.6
ValuationView details →
P/E (Fwd)
27.4x
EV/EBITDA
30.0x
Market Cap
$49.67B
RSI (14)
34.6
MomentumView details →
1D Return
−0.62%
YTD Return
+0.96%
SummaryUpdated Jun 1, 2026
Edwards Lifesciences Corporation (NYSE:EW) is a leading medical device company founded in 1958 and headquartered in Irvine, California. The company has evolved from its origins as a division of American Hospital Supply Corporation to become a specialized leader in structural heart disease and critical care monitoring technologies. Edwards went public in 2000 and has since focused increasingly on structural heart therapies, completing the sale of its Critical Care business in 2024 to concentrate solely on treating heart valve diseases and related conditions.
Similar companies
Latest newsMore news →
Donald E. Bobo, Jr. retired as Corporate Vice President of Strategy and Corporate Development at Edwards Lifesciences Corp.13d agoEP Wealth Advisors LLC acquired a new position in Edwards Lifesciences Corporation by purchasing 37,702 shares valued at approximately $3,410,000, as disclosed in a recent SEC filing.18d agoB. Metzler seel. Sohn & Co. AG acquired a new position of 41,753 shares in Edwards Lifesciences Corporation during the second quarter, valued at approximately $3,777,000.19d ago